Tredje AP-fonden’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,996
| Closed | -$601K | – | 387 |
|
2025
Q1 | $601K | Hold |
3,996
| – | – | 0.01% | 409 |
|
2024
Q4 | $738K | Sell |
3,996
-3,996
| -50% | -$738K | 0.01% | 441 |
|
2024
Q3 | $1.57M | Hold |
7,992
| – | – | 0.01% | 406 |
|
2024
Q2 | $1.65M | Sell |
7,992
-126
| -2% | -$26K | 0.02% | 384 |
|
2024
Q1 | $2.2M | Hold |
8,118
| – | – | 0.02% | 344 |
|
2023
Q4 | $1.92M | Sell |
8,118
-330
| -4% | -$78K | 0.02% | 389 |
|
2023
Q3 | $1.66M | Sell |
8,448
-790
| -9% | -$155K | 0.02% | 407 |
|
2023
Q2 | $1.94M | Sell |
9,238
-1,550
| -14% | -$326K | 0.03% | 388 |
|
2023
Q1 | $2.18M | Buy |
10,788
+505
| +5% | +$102K | 0.03% | 374 |
|
2022
Q4 | $2.24M | Sell |
10,283
-3,468
| -25% | -$756K | 0.04% | 350 |
|
2022
Q3 | $2.71M | Buy |
13,751
+10,371
| +307% | +$2.04M | 0.06% | 261 |
|
2022
Q2 | $723K | Hold |
3,380
| – | – | 0.02% | 310 |
|
2022
Q1 | $960K | Hold |
3,380
| – | – | 0.02% | 318 |
|
2021
Q4 | $1.27M | Buy |
+3,380
| New | +$1.27M | 0.02% | 316 |
|